Ensure Covaxin availability if cocktail policy for booster is adopted: IMA

IMA said that the Centre should ensure the large-scale availability of Covaxin if a mixed match policy is adopted for booster doses for healthcare workers

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
IANS New Delhi
2 min read Last Updated : Dec 26 2021 | 2:33 PM IST

The Indian Medical Association (IMA) on Sunday said that the Centre should ensure the large-scale availability of Covaxin if a mixed match policy is adopted for booster doses for healthcare workers, as majority of the people have taken Covishield as their first and second doses.

"On behalf of the frontline and healthcare workers, we hail the announcement of the Prime Minister for the precautionary booster dose for healthcare and frontline workers. It is the right step as the imminent third wave by the new variant is a matter of concern.

"Omicron is at our doorstep and we need to protect our healthcare and frontline workers in all possible ways", the IMA said in a statement.

On the ongoing RDA strike which has hit all the medical services in the national capital, the IMA said that the issue of expediting PG counseling is the need of the hour to increase manpower ahead of the looming third wave threat.

The infrastructure without manpower is a futile measure, it added.

The association has also welcomed the government's decision to inoculate children between 15-18 years of age.

J.A. Jayalal, National President of the IMA, said: "The IMA also welcomes the much-awaited decision of vaccination for children from January 3. At this moment of reopening of schools, this will be the welcome step to bring additional safety to children. The vaccination process for children must be handled with much more care and constant monitoring and surveillance must be ensured."

--IANS

avr/sks/ksk/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus Vaccineindian medical associationCoronavirus TestsDrug Controller General of Indiahealthcare

First Published: Dec 26 2021 | 2:33 PM IST

Next Story